Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report
by
Ni, Yan G.
, Litwin, Virginia
, Allinson, John
, Gagnon, Audrey
, Gunsior, Michele
, Eck, Steven
, Trampont, Paul C.
, Amaravadi, Lakshmi
, Devanarayan, Viswanath
, Stevenson, Lauren
, Sheldon, Curtis
, Wang, Yow-Ming C.
, Lundsten, Kelly
, Mathews, Joel
, Pepin, Marc-Olivier
in
Best practice
/ Biomarker
/ Biomarkers
/ Biomedical and Life Sciences
/ Biomedicine
/ Drug development
/ Drug Development Initiatives for Global Health
/ Fit-for-purpose
/ Flow cytometry
/ Meeting Report
/ Pharmaceutical Sciences/Technology
/ Pharmacology/Toxicology
/ Validation
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report
by
Ni, Yan G.
, Litwin, Virginia
, Allinson, John
, Gagnon, Audrey
, Gunsior, Michele
, Eck, Steven
, Trampont, Paul C.
, Amaravadi, Lakshmi
, Devanarayan, Viswanath
, Stevenson, Lauren
, Sheldon, Curtis
, Wang, Yow-Ming C.
, Lundsten, Kelly
, Mathews, Joel
, Pepin, Marc-Olivier
in
Best practice
/ Biomarker
/ Biomarkers
/ Biomedical and Life Sciences
/ Biomedicine
/ Drug development
/ Drug Development Initiatives for Global Health
/ Fit-for-purpose
/ Flow cytometry
/ Meeting Report
/ Pharmaceutical Sciences/Technology
/ Pharmacology/Toxicology
/ Validation
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report
by
Ni, Yan G.
, Litwin, Virginia
, Allinson, John
, Gagnon, Audrey
, Gunsior, Michele
, Eck, Steven
, Trampont, Paul C.
, Amaravadi, Lakshmi
, Devanarayan, Viswanath
, Stevenson, Lauren
, Sheldon, Curtis
, Wang, Yow-Ming C.
, Lundsten, Kelly
, Mathews, Joel
, Pepin, Marc-Olivier
in
Best practice
/ Biomarker
/ Biomarkers
/ Biomedical and Life Sciences
/ Biomedicine
/ Drug development
/ Drug Development Initiatives for Global Health
/ Fit-for-purpose
/ Flow cytometry
/ Meeting Report
/ Pharmaceutical Sciences/Technology
/ Pharmacology/Toxicology
/ Validation
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report
Journal Article
Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report
2022
Request Book From Autostore
and Choose the Collection Method
Overview
This conference report summarized a full-day workshop, “best practices for the development and fit-for-purpose validation of biomarker methods,” which was held prior to the American Association of Pharmaceutical Scientists (AAPS) PharmSci360 Congress, San Antonio, TX, November 2019. The purpose of the workshop was to bring together thought leaders in biomarker assay development in order to identify which assay parameters and key statistical measures need to be considered when developing a biomarker assay. A diverse group of more than 40 scientists participated in the workshop. The workshop and subsequent working dinner stimulated robust discussion. While a consensus on best practices was not achieved, some common themes and major points to consider for biomarker assay development have been identified and agreed on. The focus of this conference report is to summarize the presentations and discussions which occurred at the workshop. Biomarker assay validation is a complex and an evolving area with discussions ongoing.
Publisher
Springer International Publishing,Springer Nature B.V,SpringerOpen
This website uses cookies to ensure you get the best experience on our website.